Fosså, S D <br/><br/>
A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.  [electronic resource] 

 -  European journal of cancer & clinical oncology  Feb 1989 
 - 389-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0277-5379 
<br/><br/><label>Standard No.: </label>10.1016/0277-5379(89)90035-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Transitional Cell--drug therapy<br/>Drug Evaluation<br/>Epirubicin--adverse effects<br/>Female<br/>Humans<br/>Leukopenia--chemically induced<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Thrombocytopenia--chemically induced<br/>Urinary Bladder Neoplasms--drug therapy